Nassiri Nader, Nassiri Nariman, Mohammadi Babak, Rahmani Laleh
Department of Ophthalmology, Imam Hossein Medical Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.
Eur J Ophthalmol. 2010 Mar-Apr;20(2):316-26. doi: 10.1177/112067211002000210.
To compare 1-site and 2-site phacotrabeculectomies with regard to visual acuity, intraocular pressure (IOP) control, antiglaucoma medication requirements, and postoperative complications.
In a randomized controlled trial, 169 eyes with coexisting visually significant cataract and glaucoma were randomly allocated into 2 groups: eyes that had a trabeculectomy in a superior quadrant combined with phacoemulsification through the same incision (1-site group; n=85) or those with a separate, temporal, clear corneal incision for phacoemulsification (2-site group; n=84). Postoperative evaluation, including visual acuity, intraocular pressure (IOP), glaucoma medication requirements, and surgical complications, was for up to 18 months.
After 18 months, there was no significant difference between the 2 groups with respect to visual acuity and antiglaucoma medication requirements. There was a 0.6 to 1.4 mmHg difference in mean IOP, with the 2-site technique demonstrating statistically significant advantage over the 1-site technique in some follow-up visits with nonparametric analysis; however, the difference cannot be clinically significant. Success rates (IOP<21 mmHg with the maximum use of medication) of 1-site and 2-site groups were 85.9% and 92.8%, respectively, which was not statistically significant (p=0.153). Nevertheless, the incidence of failure in the 1-site group was almost twice that of the 2-site group (12 vs 6). Postoperative complications were comparable in both groups.
Results for 18-month follow-ups of 1-site and 2-site phacotrabeculectomies were comparable in terms of visual acuity, antiglaucoma medication requirements, and postoperative complications. While lowering of IOP was more pronounced in the 2-site group, this was not clinically significant.
比较单切口和双切口晶状体小梁切除术在视力、眼压(IOP)控制、抗青光眼药物需求及术后并发症方面的差异。
在一项随机对照试验中,169例患有视力显著下降的白内障合并青光眼的患者被随机分为两组:一组在上方象限进行小梁切除术并通过同一切口行超声乳化术(单切口组;n = 85);另一组通过颞侧透明角膜单独切口行超声乳化术(双切口组;n = 84)。术后评估包括视力、眼压(IOP)、抗青光眼药物需求及手术并发症,随访时间长达18个月。
18个月后,两组在视力和抗青光眼药物需求方面无显著差异。平均眼压相差0.6至1.4 mmHg,在一些随访中,双切口技术经非参数分析显示出相对于单切口技术有统计学意义的优势;然而,这种差异在临床上并不显著。单切口组和双切口组的成功率(最大药物用量下眼压<21 mmHg)分别为85.9%和92.8%,差异无统计学意义(p = 0.153)。尽管如此,单切口组的失败发生率几乎是双切口组的两倍(12例对6例)。两组术后并发症相当。
单切口和双切口晶状体小梁切除术18个月的随访结果在视力、抗青光眼药物需求及术后并发症方面相当。虽然双切口组眼压降低更明显,但在临床上并不显著。